Increased Oversight of Drug Discount Savings Use in 340B Program.
This bill introduces new transparency rules for healthcare facilities participating in the 340B drug discount program. These facilities must now permit audits to determine how they use the financial savings generated from purchasing discounted drugs. The goal is to ensure that these funds are dedicated to improving patient care, rather than being diverted elsewhere.
Key points
Covered entities must allow audits to determine how they use the net income derived from discounted drug purchases.
Increased transparency aims to prevent misuse of funds and ensure that 340B program savings benefit patients.
Entities are required to retain and provide records necessary for carrying out these audits.
Expired
Citizen Poll